Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire S Allardyce

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Dalton Transactions (Cambridge, England : 2003)|January 29, 2016
Metal-based drugs that break the rulesClaire S Allardyce, Paul J Dyson
Chimia|October 7, 2017
Light in Medicine: The Interplay of Chemistry and LightClaire S Allardyce, Roland Bays, Nicolas Thévenaz
Chimia|October 29, 2015
Light in Medicine: The Interplay of Chemistry and LightClaire S Allardyce, Roland Bays, Nicolas Thévenaz
Chimia|October 26, 2016
Vector Control in Developing Countries: Challenges and SolutionsClaire S Allardyce, Paul J Dyson, Michael Grätzel
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrinClaire S Allardyce, Paul J Dyson, Jonathan Coffey, et al.
Chembiochem : a European Journal of Chemical Biology|October 1, 2005
A mass spectrometric and molecular modelling study of cisplatin binding to transferrinIsam Khalaila, Claire S Allardyce, Chandra S Verma, et al.
Journal of Inorganic Biochemistry|June 28, 2008
Hydrolysis study of the bifunctional antitumour compound RAPTA-C, [Ru(eta6-p-cymene)Cl2(pta)]Claudine Scolaro, Christian G Hartinger, Claire S Allardyce, et al.
Journal of the American Chemical Society|February 3, 2005
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistanceWee Han Ang, Isam Khalaila, Claire S Allardyce, et al.
Scientific Reports|May 10, 2017
Expression proteomics study to determine metallodrug targets and optimal drug combinationsRonald F S Lee, Alexey Chernobrovkin, Dorothea Rutishauser, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Dalton Transactions (Cambridge, England : 2003)|January 29, 2016
Metal-based drugs that break the rulesClaire S Allardyce, Paul J Dyson
Chimia|October 7, 2017
Light in Medicine: The Interplay of Chemistry and LightClaire S Allardyce, Roland Bays, Nicolas Thévenaz
Chimia|October 29, 2015
Light in Medicine: The Interplay of Chemistry and LightClaire S Allardyce, Roland Bays, Nicolas Thévenaz
Chimia|October 26, 2016
Vector Control in Developing Countries: Challenges and SolutionsClaire S Allardyce, Paul J Dyson, Michael Grätzel
Rapid Communications in Mass Spectrometry : RCM|April 23, 2002
Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrinClaire S Allardyce, Paul J Dyson, Jonathan Coffey, et al.
Chembiochem : a European Journal of Chemical Biology|October 1, 2005
A mass spectrometric and molecular modelling study of cisplatin binding to transferrinIsam Khalaila, Claire S Allardyce, Chandra S Verma, et al.
Journal of Inorganic Biochemistry|June 28, 2008
Hydrolysis study of the bifunctional antitumour compound RAPTA-C, [Ru(eta6-p-cymene)Cl2(pta)]Claudine Scolaro, Christian G Hartinger, Claire S Allardyce, et al.
Journal of the American Chemical Society|February 3, 2005
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistanceWee Han Ang, Isam Khalaila, Claire S Allardyce, et al.
Scientific Reports|May 10, 2017
Expression proteomics study to determine metallodrug targets and optimal drug combinationsRonald F S Lee, Alexey Chernobrovkin, Dorothea Rutishauser, et al.
Pageof 1